+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lymphoma Drugs Market Research Reports

CNS Lymphoma Market - Forecast (2020 - 2025) - Product Thumbnail Image

CNS Lymphoma Market - Forecast (2020 - 2025)

  • Report
  • March 2020
  • 104 Pages
From
From
From
From
From
From
From
From
Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2020 - Product Thumbnail Image

Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2020 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
B-Cell Lymphomas - Pipeline Insight, 2020 - Product Thumbnail Image

B-Cell Lymphomas - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
From
Indolent Lymphoma - Pipeline Insight, 2020 - Product Thumbnail Image

Indolent Lymphoma - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
Small lymphocytic lymphoma - Pipeline Insight, 2020 - Product Thumbnail Image

Small lymphocytic lymphoma - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
MALT Lymphoma - Pipeline Insight, 2020 - Product Thumbnail Image

MALT Lymphoma - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
Mantle Cell Lymphoma - Pipeline Insight, 2020 - Product Thumbnail Image

Mantle Cell Lymphoma - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
Diffuse Large B-cell Lymphoma - Pipeline Insight, 2020 - Product Thumbnail Image

Diffuse Large B-cell Lymphoma - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
From
From
Loading Indicator

Lymphoma encompasses a variety of blood cancers of the lymphatic system. Non-Hodgkin’s Lymphoma (NHL) for example, is diagnosed in over 100,000 every year in the US and EU combined. An array of expert reports in our Lymphoma Section enable you to investigate drug development strategies and market trends for NHL, Hodgkin’s Lymphoma, Skin Lymphoma, T-Cell Lymphoma, Indolent Lymphoma and other variants. Investigate key issues such as licensing, R&D, industry alliances, generic drugs (rituximab, bortezomib, doxorubicin, bleomycin, vinblastine, etc.) and the activities of major pharmaceutical players such as Bristol-Myers Squibb, GlaxoSmithKline, Hoffmann-La Roche, and Sanofi-Aventis. Show Less Read more

adroll